Fox Chase Perspectives
Fox Chase Links
Fox Chase Home Page
Fox Chase Resource and Education Center
Why Choose Fox Chase?
Support Fox Chase
Contact Us
Return to Article List

Health Information Library

Other news
Earlier today, Fox Chase Cancer Center unveiled its new website. Our marketing team has been working hard over the past year to develop a user-friendly site that will allow visitors to find everything they need to know about Fox Chase Cancer Center…fast. Our many enhancements come from input from across the center including physicians, research scientists, nurses, administrators, and the patient and family advisory council. We hope you enjoy the new FoxChase.org experience.
With 2016 fast approaching, Fox Chase Cancer Center encourages all individuals to start taking steps that could help reduce their risk for cancer. According to the American Cancer Society (ACS), more than one million Americans are diagnosed with cancer every year. Fortunately, individuals can help to prevent cancer by making healthy lifestyle choices and getting regular recommended cancer screenings.
We recently launched our Fox Chase Cancer Center Care Connect Program, which links patients with primary care physicians in their community for coordinated care. Together, Fox Chase and primary care physicians throughout the region are offering programs that support the integration of cancer prevention education, screening, treatment, and survivorship care plans into clinical practice.
When she was just 28 years old, Tracy Gatto noticed a lump on her right breast. The discovery sent panic through her. She had lost her father to cancer just a few years earlier, and worried about the possibilities.
Ted Bobroski always took his health seriously and saw his doctor twice a year for check-ups, going beyond the typical annual appointment. After losing his first wife and daughter to breast cancer, the disease was on his radar. So in December 2013 when the retired engineer was 64, something sparked some concern. His prostate-specific antigen (PSA) levels, which indicate a man’s risk of developing prostate cancer, were rising.
When Colin Thomas began work in the Fox Chase Cancer Center laboratory of Alexei Tulin, PhD, he hoped to gain valuable research experience that would prepare him for medical school and beyond. He grew up in Moorestown, N.J. and had had family treated at Fox Chase, so he knew the institution's reputation well. It was 2010 and he had just graduated from Bucknell University. He says he thought Fox Chase would be the perfect place to pursue his research goals.
October is Breast Cancer Awareness Month, and Fox Chase Cancer Center encourages women to schedule a breast cancer screening. Regular screenings and mammograms can help detect breast cancer in its early stages, when it is most likely to be treated successfully—with more treatment options, less extensive surgery, and – ultimately – better outcomes.
Biotechnology company Caris Life Sciences® recently announced it has designated Fox Chase Cancer Center a center of excellence site in the Caris Centers of Excellence for Precision Medicine Network™. Wafik El-Deiry, MD, PhD, FACP, deputy cancer center director for translational research and co-program leader of molecular therapeutics at Fox Chase, also joins the Network Steering Committee to help establish guidelines and research protocols for tumor profiling.
Fox Chase Cancer Center has welcomed several physicians who recently joined the staff, including an orthopaedic surgical oncologist, an endocrinologist, a pathologist, and several medical oncologists specializing in the treatment of gastrointestinal cancers, thoracic and head & neck cancers with a focus on pain and palliative care, and breast cancer.
Fox Chase Cancer Center has been ranked 21st among the nation's top 50 hospitals for cancer care in U.S. News & World Report's Best Hospitals 2015-2016 rankings. Fox Chase was also cited as high performing in the areas of urology; gynecology; and ear, nose, and throat.
Chemotherapy before surgery to remove the bladder improves the chance of cure for some patients with bladder cancer, but unfortunately not all patients benefit from this approach. Researchers at Fox Chase Cancer Center have now identified genetic mutations that predict response to chemotherapy in patients with muscle-invasive bladder cancer, opening new avenues for personalized treatment approaches. The findings, released online in early August in European Urology, suggest that defects in the ability to repair DNA damage represent an Achilles heel for tumors, making them more vulnerable to DNA-damaging drugs.
Health library search
Search the archives by simply typing a word and then clicking the Search button:

Fox Chase Cancer Center and Coffey Communications, Inc., all rights reserved. Terms of use.